Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Metadata
Title
US FDA backs safety of triazolam
Publication date
01-12-1997
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/1997
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-199706820-00002

Other articles of this Issue 1/1997

Reactions Weekly 1/1997 Go to the issue

Case report

Cyclophosphamide/vincristine

News item

US launch of sibutramine awaits scheduling decision

Case reports

Hyaluronan

Case report

Tamoxifen

Case report

Codeine

Case report

Hydrochlorothiazide/spironolactone/triamterene abuse